Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CAH – Cardinal Health, Inc.

Float Short %

2.07

Margin Of Safety %

-1

Put/Call OI Ratio

0.93

EPS Next Q Diff

2.88

EPS Last/This Y

1.59

EPS This/Next Y

1.26

Price

207.21

Target Price

221.73

Analyst Recom

1.75

Performance Q

32.26

Relative Volume

0.9

Beta

0.65

Ticker: CAH




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-09CAH198.10.560.3252765
2025-12-10CAH198.220.560.3753041
2025-12-11CAH198.250.560.0453092
2025-12-12CAH198.130.530.4855159
2025-12-15CAH199.940.710.4144751
2025-12-16CAH197.870.730.5145324
2025-12-17CAH198.430.740.5946983
2025-12-18CAH199.030.721.7046749
2025-12-19CAH202.90.730.8146972
2025-12-22CAH205.150.680.7038270
2025-12-23CAH207.370.690.5439072
2025-12-26CAH208.240.680.3240232
2025-12-29CAH207.320.681.2539749
2025-12-30CAH207.190.680.2239962
2025-12-31CAH205.510.680.0140550
2026-01-02CAH205.70.930.6334092
2026-01-05CAH205.430.921.2833832
2026-01-06CAH208.460.930.7234404
2026-01-07CAH207.160.930.0635803
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-12-09CAH198.0018.9623.29.83
2025-12-10CAH198.0019.0638.49.83
2025-12-11CAH198.3219.0636.29.83
2025-12-12CAH198.1619.0633.39.83
2025-12-15CAH199.9619.0660.79.83
2025-12-16CAH199.9619.0606.79.83
2025-12-17CAH198.4919.0644.09.83
2025-12-18CAH199.0319.0643.99.83
2025-12-19CAH202.8519.0688.39.83
2025-12-22CAH205.0319.0664.39.83
2025-12-23CAH207.2819.0664.09.83
2025-12-26CAH208.2819.0645.69.83
2025-12-29CAH207.3819.0623.49.83
2025-12-30CAH207.2419.0633.79.83
2025-12-31CAH205.5419.0613.09.83
2026-01-02CAH205.7019.0638.39.83
2026-01-05CAH205.2419.0636.09.83
2026-01-06CAH208.5019.0684.39.83
2026-01-07CAH207.2119.0625.59.83
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-12-09CAH-36.492.333.40
2025-12-10CAH-36.492.332.66
2025-12-11CAH-36.492.332.66
2025-12-12CAH-36.492.332.66
2025-12-15CAH-36.492.322.66
2025-12-16CAH-36.492.322.66
2025-12-17CAH-36.492.322.66
2025-12-18CAH-36.492.322.66
2025-12-19CAH-36.492.322.66
2025-12-22CAH-36.492.242.66
2025-12-23CAH-36.492.242.66
2025-12-26CAH-36.492.242.07
2025-12-29CAH-36.492.252.07
2025-12-30CAH-36.492.252.07
2025-12-31CAH-36.492.252.07
2026-01-02CAH-36.492.252.07
2026-01-05CAH-36.492.282.07
2026-01-06CAH-36.492.282.07
2026-01-07CAH-36.492.282.07
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

-0.19

Avg. EPS Est. Current Quarter

2.3

Avg. EPS Est. Next Quarter

2.69

Insider Transactions

-36.49

Institutional Transactions

2.28

Beta

0.65

Average Sales Estimate Current Quarter

64878

Average Sales Estimate Next Quarter

62767

Fair Value

204.85

Quality Score

66

Growth Score

91

Sentiment Score

43

Actual DrawDown %

3.6

Max Drawdown 5-Year %

-24.7

Target Price

221.73

P/E

31.28

Forward P/E

18.71

PEG

1.27

P/S

0.21

P/B

P/Free Cash Flow

11.06

EPS

6.62

Average EPS Est. Cur. Y​

9.83

EPS Next Y. (Est.)

11.08

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

0.68

Relative Volume

0.9

Return on Equity vs Sector %

-82.5

Return on Equity vs Industry %

-479.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.05

EBIT Estimation

625.5
Cardinal Health, Inc.
Sector: Healthcare
Industry: Medical Distribution
Employees: 53084
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
stock quote shares CAH – Cardinal Health, Inc. Stock Price stock today
news today CAH – Cardinal Health, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CAH – Cardinal Health, Inc. yahoo finance google finance
stock history CAH – Cardinal Health, Inc. invest stock market
stock prices CAH premarket after hours
ticker CAH fair value insiders trading

PBH – Prestige Consumer Healthcare Inc.

Float Short %

4.51

Margin Of Safety %

10

Put/Call OI Ratio

0.4

EPS Next Q Diff

0.33

EPS Last/This Y

0.23

EPS This/Next Y

0.29

Price

62.77

Target Price

78.2

Analyst Recom

1.43

Performance Q

-0.22

Relative Volume

0.57

Beta

0.43

Ticker: PBH




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-09PBH59.940.520.00240
2025-12-10PBH61.340.500.00245
2025-12-11PBH60.870.500.00245
2025-12-12PBH61.470.500.00245
2025-12-15PBH61.850.510.00243
2025-12-16PBH61.620.510.00243
2025-12-17PBH62.310.470.00291
2025-12-18PBH61.990.470.00291
2025-12-19PBH61.70.470.00290
2025-12-22PBH62.690.470.00291
2025-12-23PBH62.340.470.00291
2025-12-26PBH62.880.470.00291
2025-12-29PBH63.620.470.50292
2025-12-30PBH62.190.470.50292
2025-12-31PBH61.660.470.00293
2026-01-02PBH61.220.470.00293
2026-01-05PBH62.470.470.00293
2026-01-06PBH62.730.470.00293
2026-01-07PBH62.720.402.00331
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-12-09PBH59.94-3.214.94.55
2025-12-10PBH61.36-3.222.84.55
2025-12-11PBH60.87-3.214.54.55
2025-12-12PBH61.44-3.219.14.55
2025-12-15PBH61.86-3.218.44.55
2025-12-16PBH61.86-3.215.74.55
2025-12-17PBH62.31-3.219.64.55
2025-12-18PBH61.97-3.215.14.55
2025-12-19PBH61.80-3.216.04.55
2025-12-22PBH62.74-3.220.84.55
2025-12-23PBH62.26-3.215.24.55
2025-12-26PBH62.89-3.218.64.55
2025-12-29PBH63.67-3.220.24.55
2025-12-30PBH62.22-3.210.44.55
2025-12-31PBH61.68-3.214.24.55
2026-01-02PBH61.24-3.214.74.55
2026-01-05PBH62.43-3.221.84.55
2026-01-06PBH62.77-3.217.84.55
2026-01-07PBH62.77-3.216.64.55
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-12-09PBH-0.57-1.053.32
2025-12-10PBH-0.57-1.053.77
2025-12-11PBH-0.57-1.053.77
2025-12-12PBH-0.57-1.053.77
2025-12-15PBH-0.57-1.203.77
2025-12-16PBH-0.56-1.203.77
2025-12-17PBH-0.56-1.203.77
2025-12-18PBH-0.56-1.203.77
2025-12-19PBH-0.56-1.203.77
2025-12-22PBH-0.56-1.233.77
2025-12-23PBH-0.56-1.233.77
2025-12-26PBH-0.56-1.234.51
2025-12-29PBH-0.56-1.224.51
2025-12-30PBH-0.56-1.224.51
2025-12-31PBH-0.56-1.224.51
2026-01-02PBH-0.56-1.224.51
2026-01-05PBH-0.56-1.224.51
2026-01-06PBH-0.56-1.224.51
2026-01-07PBH-0.56-1.224.51
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

1.07

Avg. EPS Est. Current Quarter

1.18

Avg. EPS Est. Next Quarter

1.4

Insider Transactions

-0.56

Institutional Transactions

-1.22

Beta

0.43

Average Sales Estimate Current Quarter

286

Average Sales Estimate Next Quarter

301

Fair Value

69.13

Quality Score

86

Growth Score

69

Sentiment Score

9

Actual DrawDown %

30.3

Max Drawdown 5-Year %

-35.5

Target Price

78.2

P/E

15.56

Forward P/E

12.9

PEG

3.77

P/S

2.72

P/B

1.65

P/Free Cash Flow

11.81

EPS

4.03

Average EPS Est. Cur. Y​

4.55

EPS Next Y. (Est.)

4.84

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

18.09

Relative Volume

0.57

Return on Equity vs Sector %

-16.1

Return on Equity vs Industry %

3.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

16.6
Prestige Consumer Healthcare In
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 600
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
stock quote shares PBH – Prestige Consumer Healthcare Inc. Stock Price stock today
news today PBH – Prestige Consumer Healthcare Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PBH – Prestige Consumer Healthcare Inc. yahoo finance google finance
stock history PBH – Prestige Consumer Healthcare Inc. invest stock market
stock prices PBH premarket after hours
ticker PBH fair value insiders trading

PDCO – Patterson Companies, Inc.

Float Short %

3.53

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

-0.43

EPS Last/This Y

EPS This/Next Y

Price

31.33

Target Price

31.35

Analyst Recom

3

Performance Q

1.42

Relative Volume

Beta

0.62

Ticker: PDCO




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-09PDCO31.33N/AN/A0
2025-12-10PDCO31.33N/AN/A0
2025-12-11PDCO31.33N/AN/A0
2025-12-12PDCO31.33N/AN/A0
2025-12-15PDCO31.33N/AN/A0
2025-12-16PDCO31.33N/AN/A0
2025-12-17PDCO31.33N/AN/A0
2025-12-18PDCO31.33N/AN/A0
2025-12-19PDCO31.33N/AN/A0
2025-12-22PDCO31.33N/AN/A0
2025-12-23PDCO31.33N/AN/A0
2025-12-26PDCO31.33N/AN/A0
2025-12-29PDCO31.33N/AN/A0
2025-12-30PDCO31.33N/AN/A0
2025-12-31PDCO31.33N/AN/A0
2026-01-02PDCO31.33N/AN/A0
2026-01-05PDCO31.33N/AN/A0
2026-01-06PDCO31.33N/AN/A0
2026-01-07PDCO31.33N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




No data found




No data found

Last Quarter Act. EPS

0.43

Avg. EPS Est. Current Quarter

0.85

Avg. EPS Est. Next Quarter

Insider Transactions

-0.02

Institutional Transactions

-6

Beta

0.62

Average Sales Estimate Current Quarter

1768

Average Sales Estimate Next Quarter

Fair Value

Quality Score

69

Growth Score

69

Sentiment Score

68

Actual DrawDown %

16.2

Max Drawdown 5-Year %

-40

Target Price

31.35

P/E

20.21

Forward P/E

PEG

P/S

0.43

P/B

2.8

P/Free Cash Flow

EPS

1.55

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

2.13

Relative Volume

Return on Equity vs Sector %

-7.2

Return on Equity vs Industry %

357.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

79.8
stock quote shares PDCO – Patterson Companies, Inc. Stock Price stock today
news today PDCO – Patterson Companies, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PDCO – Patterson Companies, Inc. yahoo finance google finance
stock history PDCO – Patterson Companies, Inc. invest stock market
stock prices PDCO premarket after hours
ticker PDCO fair value insiders trading

HSIC – Henry Schein, Inc.

Float Short %

5.9

Margin Of Safety %

8

Put/Call OI Ratio

0.19

EPS Next Q Diff

-0.11

EPS Last/This Y

1.84

EPS This/Next Y

0.37

Price

78.12

Target Price

77.64

Analyst Recom

2.5

Performance Q

20.44

Relative Volume

0.66

Beta

0.88

Ticker: HSIC




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-09HSIC74.440.190.1516742
2025-12-10HSIC75.830.200.0016602
2025-12-11HSIC76.230.200.0016603
2025-12-12HSIC76.540.200.8016607
2025-12-15HSIC77.410.190.3316605
2025-12-16HSIC77.080.1970.0016619
2025-12-17HSIC76.610.220.3317004
2025-12-18HSIC77.030.220.8317021
2025-12-19HSIC77.360.220.5617035
2025-12-22HSIC77.580.190.0716403
2025-12-23HSIC76.510.1928.2216420
2025-12-26HSIC76.150.200.0116605
2025-12-29HSIC76.430.200.5016610
2025-12-30HSIC76.460.200.1316613
2025-12-31HSIC75.560.200.6316613
2026-01-02HSIC76.830.200.0116622
2026-01-05HSIC78.550.200.0016996
2026-01-06HSIC78.530.200.0517215
2026-01-07HSIC78.130.190.0717252
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-12-09HSIC74.448.8368.94.91
2025-12-10HSIC74.448.8367.44.91
2025-12-11HSIC76.248.9356.84.91
2025-12-12HSIC76.548.9356.04.91
2025-12-15HSIC77.398.9361.34.91
2025-12-16HSIC77.398.9353.04.91
2025-12-17HSIC76.608.9348.64.91
2025-12-18HSIC77.018.9357.14.91
2025-12-19HSIC77.358.9356.44.91
2025-12-22HSIC77.828.9357.84.91
2025-12-23HSIC76.538.9342.54.91
2025-12-26HSIC76.118.9352.34.91
2025-12-29HSIC76.438.9356.04.91
2025-12-30HSIC76.468.9353.34.91
2025-12-31HSIC75.608.9344.84.91
2026-01-02HSIC76.808.9365.24.91
2026-01-05HSIC78.568.9370.14.91
2026-01-06HSIC78.538.9352.94.91
2026-01-07HSIC78.128.9349.04.91
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-12-09HSIC0.05-4.877.19
2025-12-10HSIC0.05-4.876.58
2025-12-11HSIC0.05-4.876.58
2025-12-12HSIC0.05-4.876.58
2025-12-15HSIC0.05-4.876.64
2025-12-16HSIC0.05-4.876.64
2025-12-17HSIC0.05-4.876.64
2025-12-18HSIC0.05-4.876.64
2025-12-19HSIC0.05-4.876.64
2025-12-22HSIC0.05-4.856.64
2025-12-23HSIC0.05-4.856.64
2025-12-26HSIC0.05-4.855.90
2025-12-29HSIC0.05-4.805.90
2025-12-30HSIC0.05-4.805.90
2025-12-31HSIC0.05-4.805.90
2026-01-02HSIC0.05-4.805.90
2026-01-05HSIC0.05-4.845.90
2026-01-06HSIC0.05-4.845.90
2026-01-07HSIC0.05-4.845.90
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

1.38

Avg. EPS Est. Current Quarter

1.3

Avg. EPS Est. Next Quarter

1.27

Insider Transactions

0.05

Institutional Transactions

-4.84

Beta

0.88

Average Sales Estimate Current Quarter

3347

Average Sales Estimate Next Quarter

3314

Fair Value

84.28

Quality Score

65

Growth Score

77

Sentiment Score

65

Actual DrawDown %

15.7

Max Drawdown 5-Year %

-32.7

Target Price

77.64

P/E

24.69

Forward P/E

14.74

PEG

2.02

P/S

0.71

P/B

2.76

P/Free Cash Flow

22.83

EPS

3.17

Average EPS Est. Cur. Y​

4.91

EPS Next Y. (Est.)

5.28

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

3.02

Relative Volume

0.66

Return on Equity vs Sector %

-15.4

Return on Equity vs Industry %

-412.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

349
Henry Schein, Inc.
Sector: Healthcare
Industry: Medical Distribution
Employees: 25000
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair; and branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins. It also provides financial services on a nonrecourse basis, education services for practitioners, consulting, and other services; and consumable merchandise under its own brand. In addition, the company manufactures, markets, and sells dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other health care-related products and services. Further, it is involved in the development and distribution of practice management software, e-services, and other products to health care providers. The company serves customers in dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
stock quote shares HSIC – Henry Schein, Inc. Stock Price stock today
news today HSIC – Henry Schein, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch HSIC – Henry Schein, Inc. yahoo finance google finance
stock history HSIC – Henry Schein, Inc. invest stock market
stock prices HSIC premarket after hours
ticker HSIC fair value insiders trading

OMI – Owens & Minor, Inc.

Float Short %

13.52

Margin Of Safety %

Put/Call OI Ratio

0.21

EPS Next Q Diff

-1.68

EPS Last/This Y

5.75

EPS This/Next Y

-0.05

Price

2.32

Target Price

5.64

Analyst Recom

3

Performance Q

-44.22

Relative Volume

0.65

Beta

1.35

Ticker: OMI




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-09OMI2.50.180.1328451
2025-12-10OMI2.760.181.5029126
2025-12-11OMI2.950.180.0729180
2025-12-12OMI3.020.180.0329917
2025-12-15OMI3.020.180.3429865
2025-12-16OMI3.110.170.0030095
2025-12-17OMI3.110.170.1930122
2025-12-18OMI3.150.171.0630127
2025-12-19OMI2.830.160.9529772
2025-12-22OMI2.670.252.5016684
2025-12-23OMI2.650.250.0016730
2025-12-26OMI2.770.220.0618504
2025-12-29OMI2.760.210.2519051
2025-12-30OMI2.740.210.0219005
2025-12-31OMI2.80.210.2719023
2026-01-02OMI2.80.210.3919023
2026-01-05OMI2.80.210.3919023
2026-01-06OMI2.80.210.3919023
2026-01-07OMI2.80.210.3919023
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




17 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-12-09OMI2.49-58.7497.71.02
2025-12-10OMI2.76-58.7499.91.02
2025-12-11OMI2.96-58.7499.41.02
2025-12-12OMI3.01-58.7498.41.02
2025-12-15OMI3.01-58.7498.01.02
2025-12-16OMI3.01-58.7498.61.02
2025-12-17OMI3.11-58.7498.01.02
2025-12-18OMI3.16-58.7498.31.02
2025-12-19OMI2.82-58.7495.71.02
2025-12-22OMI2.74-58.7497.21.02
2025-12-23OMI2.64-58.7497.71.02
2025-12-26OMI2.76-58.7498.31.02
2025-12-29OMI2.76-58.7497.91.02
2025-12-30OMI2.75-58.7497.91.02
2025-12-31OMI2.80-58.7498.41.02
2026-01-02OMI2.80-58.7498.01.02
2026-01-05OMI2.32-58.7498.01.02
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
17 items Current Page1 of 1




15 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-12-09OMI100.33-4.3913.09
2025-12-10OMI100.33-4.3913.52
2025-12-11OMI100.33-4.3913.52
2025-12-12OMI100.33-4.3913.52
2025-12-15OMI100.33-4.4113.51
2025-12-16OMI100.33-4.4113.50
2025-12-17OMI106.80-4.4113.50
2025-12-18OMI106.80-4.4113.50
2025-12-19OMI106.79-4.4113.50
2025-12-22OMI106.80-4.1613.50
2025-12-23OMI106.80-4.1613.50
2025-12-26OMI106.80-4.1613.52
2025-12-29OMI106.80-4.1713.52
2025-12-30OMI106.80-4.1713.52
2025-12-31OMI106.79-4.1713.52
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
15 items Current Page1 of 1

Last Quarter Act. EPS

1.83

Avg. EPS Est. Current Quarter

0.23

Avg. EPS Est. Next Quarter

0.15

Insider Transactions

106.79

Institutional Transactions

-4.17

Beta

1.35

Average Sales Estimate Current Quarter

714

Average Sales Estimate Next Quarter

654

Fair Value

Quality Score

20

Growth Score

27

Sentiment Score

1

Actual DrawDown %

95.3

Max Drawdown 5-Year %

-95.2

Target Price

5.64

P/E

Forward P/E

2.88

PEG

P/S

0.03

P/B

P/Free Cash Flow

EPS

-17.4

Average EPS Est. Cur. Y​

1.02

EPS Next Y. (Est.)

0.97

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-19.98

Relative Volume

0.65

Return on Equity vs Sector %

284.8

Return on Equity vs Industry %

-124.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

498
Owens & Minor, Inc.
Sector: Healthcare
Industry: Medical Distribution
Employees: 23200
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Accendra Health, Inc. was formerly known as Owens & Minor, Inc. and changed its name Accendra Health, Inc. in December 2025. The company was founded in 1882 and is based in Glen Allen, Virginia.
stock quote shares OMI – Owens & Minor, Inc. Stock Price stock today
news today OMI – Owens & Minor, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch OMI – Owens & Minor, Inc. yahoo finance google finance
stock history OMI – Owens & Minor, Inc. invest stock market
stock prices OMI premarket after hours
ticker OMI fair value insiders trading

MCK – McKesson Corporation

Float Short %

1.72

Margin Of Safety %

4

Put/Call OI Ratio

0.74

EPS Next Q Diff

1.43

EPS Last/This Y

12.82

EPS This/Next Y

5.14

Price

823.38

Target Price

948.67

Analyst Recom

1.65

Performance Q

9.84

Relative Volume

0.88

Beta

0.41

Ticker: MCK




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-09MCK795.010.730.5819637
2025-12-10MCK812.750.740.6920004
2025-12-11MCK815.640.740.3520103
2025-12-12MCK813.580.731.1920384
2025-12-15MCK822.590.710.8818917
2025-12-16MCK809.980.713.3619050
2025-12-17MCK806.550.766.4419764
2025-12-18MCK810.510.802.0220261
2025-12-19MCK819.50.792.0020193
2025-12-22MCK818.230.791.4918859
2025-12-23MCK825.730.810.2719218
2025-12-26MCK828.460.790.2719864
2025-12-29MCK830.120.830.3818704
2025-12-30MCK827.630.830.4718928
2025-12-31MCK820.160.820.3219232
2026-01-02MCK823.310.771.8420551
2026-01-05MCK824.480.760.4820237
2026-01-06MCK826.790.770.1920638
2026-01-07MCK823.380.741.0521244
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-12-09MCK795.0115.51301.438.67
2025-12-10MCK813.4115.51472.138.68
2025-12-11MCK815.5115.51343.638.68
2025-12-12MCK813.6415.51309.938.68
2025-12-15MCK823.0115.51396.938.68
2025-12-16MCK823.0115.51223.038.68
2025-12-17MCK806.8515.51300.238.68
2025-12-18MCK810.4115.51355.538.68
2025-12-19MCK819.5515.51395.438.68
2025-12-22MCK818.6015.51311.938.68
2025-12-23MCK824.8415.51374.938.68
2025-12-26MCK828.6215.51341.638.68
2025-12-29MCK830.2615.51334.238.68
2025-12-30MCK827.3515.51295.238.68
2025-12-31MCK819.9915.51262.238.68
2026-01-02MCK823.5115.51343.838.68
2026-01-05MCK824.6615.51328.338.68
2026-01-06MCK826.5515.51331.438.68
2026-01-07MCK823.3815.51294.638.68
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-12-09MCK-63.08-1.191.54
2025-12-10MCK-54.24-1.191.63
2025-12-11MCK-54.24-1.191.63
2025-12-12MCK-54.24-1.191.63
2025-12-15MCK-54.24-0.751.63
2025-12-16MCK-54.24-0.751.63
2025-12-17MCK-54.24-0.751.63
2025-12-18MCK-54.24-0.751.63
2025-12-19MCK-54.24-0.751.63
2025-12-22MCK-54.24-0.971.63
2025-12-23MCK-54.24-0.971.63
2025-12-26MCK-54.24-0.971.72
2025-12-29MCK-54.24-0.971.72
2025-12-30MCK-54.24-0.971.72
2025-12-31MCK-54.24-0.971.72
2026-01-02MCK-54.24-0.971.72
2026-01-05MCK-54.24-0.941.72
2026-01-06MCK-54.40-0.941.72
2026-01-07MCK-54.40-0.941.72
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

9.86

Avg. EPS Est. Current Quarter

9.28

Avg. EPS Est. Next Quarter

11.29

Insider Transactions

-54.4

Institutional Transactions

-0.94

Beta

0.41

Average Sales Estimate Current Quarter

105982

Average Sales Estimate Next Quarter

101447

Fair Value

856.96

Quality Score

71

Growth Score

86

Sentiment Score

72

Actual DrawDown %

8.1

Max Drawdown 5-Year %

-23.9

Target Price

948.67

P/E

25.65

Forward P/E

18.79

PEG

1.28

P/S

0.26

P/B

P/Free Cash Flow

16

EPS

32.12

Average EPS Est. Cur. Y​

38.68

EPS Next Y. (Est.)

43.82

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

1.04

Relative Volume

0.88

Return on Equity vs Sector %

-259

Return on Equity vs Industry %

-656.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.09

EBIT Estimation

1294.6
McKesson Corporation
Sector: Healthcare
Industry: Medical Distribution
Employees: 43000
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
stock quote shares MCK – McKesson Corporation Stock Price stock today
news today MCK – McKesson Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch MCK – McKesson Corporation yahoo finance google finance
stock history MCK – McKesson Corporation invest stock market
stock prices MCK premarket after hours
ticker MCK fair value insiders trading
No more stocks to show